Evaluation of the developmental toxicity of theophylline, dimethyluric acid, and methylxanthine metabolites using Xenopus

Drug and Chemical Toxicology

Volumn 19, Issue 4, 1996, Pages 267-278

  Fort, Douglas J ^a,c   Stover, Enos L ^a   Propst, Timothy ^a   Hull, Mendi A ^b   Bantle, John A ^b  

^a Stover Group   (United States)

^b OKLAHOMA STATE UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYLXANTHINE; 1,3 DIMETHYLURIC ACID; 3 METHYLXANTHINE; DRUG METABOLITE; THEOPHYLLINE; UNSPECIFIC MONOOXYGENASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYOTOXICITY; METABOLIC ACTIVATION; NONHUMAN; REPRODUCTIVE TOXICITY; XENOPUS;

EID: 0030447131     PISSN: 01480545     EISSN: None     Source Type: Journal    
DOI: 10.3109/01480549608998237     Document Type: Article

References (29)

1. J.J. Grygiel and D.J. Birkett, Clin. Pharmacol. Ther., 30, 491 (1981).
2. L. Hendeles, Weinberger, Pharmacotherapy, 3, 2 (1983).
3. J.J. Grygiel, J.O. Miners, R. Drew, and D.J. Birkett, Euro. J. Clin. Pharmacol., 26, 335 (1984).
4. R.A. Robson, J.O. Miners, L.M.H. Wing, and D.J. Birkett, Br. J. Clin. Pharmacol., 18, 445 (1984).
5. J.O. Miners, L.M.H. Wing, K.J. Lillywhite, and R.A. Robson, Br. J. Clin. Pharmacol., 20, 219 (1985).
6. M.E. Campbell, D.M. Grant, T. Inaka, and W. Kalow, (1987).
7. J.F. Williams, S. Lowitt, and A. Szentwanyi, Biochem. Pharmacol., 28, 2935 (1979).
8. C.J. Betlach and T.N. Tozer, Drug Metab. Dispos. 8, 271 (1980).
9. J.N. Dumont, T. W. Schultz, M. Buchanan, and G. Kai, in "Symposium on the Application of Short-Term Bioassays in the Analysis of Complex Environmental Mixtures III," M.D. Waters, S.S. Sandhu, J. Lewtas, L. Claxton, N. Chernoff, and S. Nesnow, eds., New York, 393 (1983).
10. D.J. Fort, D.A. Dawson, and J.A. Bantle, Teratogenesis Carcinogen Mutagen, 8, 251 (1988).
11. D.J. Fort, D.A. Dawson, and J.A. Banatle, J. Appl. Toxicol., 14, 143 (1989).
12. D.J. Fort, J.R. Rayburn, D.J. DeYoung, and J.A. Bantle, Drug Chem. Toxicol., 14, 143 (1991).
13. D.A. Dawson, D.J. Fort, G.J. Smith, D.L. Newell, and J.A. Bantle, Teratogenesis Caracinogen Mutagen, 8, 329 (1988).
14. D.J. Fort and J.A. Bantle, Fund. Appl. Toxicol., 14, 720 (1990).
15. D.J. Fort and J.A. Bantle, Teratogenesis Carcinogen Mutagen, 10, 463 (1990).
16. D.J. Fort, J.R. Rayburn, and J.A. Bantle, Drug Chem. Toxicol., (1992).
17. D.J. Fort, E.L. Stover, J.R. Rayburn, M. Hull, and J.A. Bantle, Teratogenesis Carcinogen Mutagen, 13, 35 (1993).
18. G. Lucier, O. McDaniel, P. Brubaker, and R. Klein, Chem. Biol. Interact, 4, 265 (1971).
19. T. Nash, Biochemistry, 55, 412 (1955).
20. M.M. Bradford, Anal. Biochem., 72, 248 (1976).
21. D.A. Dawson and J.A. Bantle, J. Appl. Toxicol., 7, 237 (1987).
22. P.D. Nieuwkoop and J. Farber, in "Normal Tables of Xenopus laevis (Daudin)," Amsterdam, North Holland (1975).
23. R.J. Tallarida and R.B. Murray, in "Manual of Pharmacologicla Calculations with Computer Programs," New York, Springer-Verlag (1980).
24. D.A. Dawson and J.A. Bantle, Teratology, 35, 221 (1987).
25. T. Von Kreybig, Naunyn. Schmiedebergs. Arch. Pharmacol., 252, 173 (1965).
26. S. Chaube, G. Kury, and M.L. Murphy, Cancer Chemother. Rep., 51, 363 (1978).
27. S. Singh, Indian J. Med. Res., 59, 1128 (1971).
28. R. Shogi and E. Ohzu, J. Fac. Sc. Hokkaido Univ., (Ser VI) 15, 662 (1965).
29. J.E. Gibson and B.A. Becker, Cancer Res., 28, 475 (1968).